Intelligent Data Capture (IDC) Enables Optimal Xevo G2-XS Data Acquisition and Processing for Multi-Attribute Method (MAM) Studies
Applications | 2021 | WatersInstrumentation
Multi-Attribute Method (MAM) is critical for direct measurement of product and critical quality attributes in biopharmaceutical development, enabling simultaneous attribute monitoring, impurity detection, and new peak identification.
This study evaluates the impact of the Intelligent Data Capture (IDC) noise reduction algorithm on the Xevo G2-XS QTof system for peptide-level MAM analysis. Key aims include assessing quantitative fidelity, new peak detection performance, raw data file size reduction, and data processing speed across IDC threshold settings (Off, 5, 10, 15).
Sample Set:
Quantitative Fidelity:
Implementing IDC on the Xevo G2-XS QTof delivers reproducible peptide MAM results while dramatically reducing raw data sizes and processing times. The default IDC15 setting offers optimal noise suppression, eliminates false-positive new peaks, and enhances overall workflow efficiency, supporting robust quality monitoring in biopharmaceutical development.
HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesPharma & Biopharma, Proteomics
ManufacturerWaters
Summary
Importance of the Topic
Multi-Attribute Method (MAM) is critical for direct measurement of product and critical quality attributes in biopharmaceutical development, enabling simultaneous attribute monitoring, impurity detection, and new peak identification.
Objectives and Study Overview
This study evaluates the impact of the Intelligent Data Capture (IDC) noise reduction algorithm on the Xevo G2-XS QTof system for peptide-level MAM analysis. Key aims include assessing quantitative fidelity, new peak detection performance, raw data file size reduction, and data processing speed across IDC threshold settings (Off, 5, 10, 15).
Methodology
Sample Set:
- System suitability: MassPREP peptide mixture
- Control: Tryptic digestion mAb standard
- Spiked control: mAb digest with 15 heavy-labeled peptides
- Stressed sample: NISTmAb incubated at pH 8.0, 40 °C for 14 days then digested
- ACQUITY UPLC H-Class PLUS Bio System
- ACQUITY Premier Peptide CSH C18 column, 60 °C, 0.2 mL/min
- Mobile phases: 0.1% formic acid in water (A), 0.1% formic acid in acetonitrile (B)
- Injection volume: 10 µL; sample temperature: 6 °C
- Xevo G2-XS QTof, ESI+ in MSE mode, m/z 50–2000
- Capillary voltage: 1.2 kV; cone voltage: 20 V; collision energy ramp: 60–120 V
- waters_connect platform with Peptide MAM and UNIFI applications
Used Instrumentation
- ACQUITY UPLC H-Class PLUS Bio System
- ACQUITY UPLC Tunable UV Detector
- Xevo G2-XS QTof MS
- waters_connect informatics with Peptide MAM and UNIFI apps
Main Results and Discussion
Quantitative Fidelity:
- % modification profiles for 30 attributes, including low-abundance glycopeptides (Man5 at ~0.08%), remained consistent across IDC Off and IDC15 settings.
- IDC15 spectra demonstrated reduced baseline noise and preserved isotope distributions for weak signals.
- IDC15 acquisition identified all true new peaks in spiked and stressed samples while eliminating false positives observed at IDC5 and IDC Off.
- Lower IDC thresholds and no IDC increased manual validation workload due to artifacts.
- IDC5 reduced raw file size by 65%; IDC15 achieved over 90% reduction versus IDC Off.
- Data processing times decreased by up to 75% at IDC15, saving more than three hours for two injections.
Benefits and Practical Applications
- Streamlined, compliance-ready peptide MAM workflows with minimal manual intervention.
- Enhanced confidence in new peak detection, reducing regulatory risks and out-of-specification investigations.
- Significant data storage savings and faster data analysis without loss of sensitivity or quantitation accuracy.
Future Trends and Applications
- Extension of real-time noise reduction algorithms to other mass spectrometry platforms and omics workflows.
- Integration of AI-driven data analysis for adaptive thresholding and enhanced feature extraction.
- Wider regulatory acceptance of MAM workflows embedded with intelligent data reduction and automated reporting.
Conclusion
Implementing IDC on the Xevo G2-XS QTof delivers reproducible peptide MAM results while dramatically reducing raw data sizes and processing times. The default IDC15 setting offers optimal noise suppression, eliminates false-positive new peaks, and enhances overall workflow efficiency, supporting robust quality monitoring in biopharmaceutical development.
Reference
- Mortishire-Smith R, Richardson K, Denny R, Hughes C. Intelligent Data Capture: Real-Time Noise Reduction for High Resolution Mass Spectrometry. Waters White Paper, 720006567EN (2019).
- Ippoliti S, Yu YQ, Mortishire-Smith R. Peptide Mapping Using Intelligent Data Capture on Vion IMS QTof. Waters Application Brief, 720006636EN (2019).
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Multi-Attribute Methods for Biopharmaceutical Analysis
2022|Waters|Guides
[ APPLICATION NOTEBOOK ] Multi-Attribute Methods for Biopharmaceutical Analysis Application Notes [ APPLICATION NOTEBOOK ] Introduction The adoption of LC-MS-based multi-attribute method (MAM) analysis for routine monitoring of biotherapeutic variation has progressed greatly over the last five years. The ability…
Key words
notebook, notebookattribute, attributebiopharmaceutical, biopharmaceuticalreturn, returnmulti, multimam, mamapplication, applicationcontents, contentspeptide, peptideattributes, attributesmethods, methodsacquity, acquitymab, mabbioaccord, bioaccordmonitoring
Extending the Capabilities of the BioAccord LC-MS System with a streamlined workflow for compliant-ready Multi-Attribute Method (MAM)
2020|Waters|Applications
Application Note Extending the Capabilities of the BioAccord LC-MS System with a streamlined workflow for compliant-ready Multi-Attribute Method (MAM) Nilini Ranbaduge, Ying Qing Yu Waters Corporation This is an Application Brief and does not contain a detailed Experimental section. Abstract…
Key words
mam, mampeptide, peptidepcqas, pcqasbioaccord, bioaccordworkflow, workflowattributes, attributesattribute, attributestreamlined, streamlinedcharacterization, characterizationfrom, fromend, endregulated, regulatedmanaging, managingcapabilities, capabilitiesbiotherapeutic
Peptide Mapping Using Intelligent Data Capture on Vion IMS QTof
2019|Waters|Technical notes
[ TECHNOLOGY BRIEF ] Peptide Mapping Using Intelligent Data Capture on Vion IMS QTof Samantha Ippoliti, Ying Qing Yu, and Russell Mortishire-Smith Waters Corporation, Milford, MA, USA Real-time file size and noise reduction to speed up data processing and provide…
Key words
idc, idcfile, filedata, datapeptide, peptidesize, sizemapping, mappingnoise, noisevion, vioncapture, captureintelligent, intelligentreduction, reductionims, imsreal, realchains, chainsqtof
Applying Peptide Mapping and Multi- Attribute Method (MAM) Workflow for Biosimilar mAb Drug Products Comparison on the Xevo™ G3 QTof Platform
2022|Waters|Applications
Application Note Applying Peptide Mapping and MultiAttribute Method (MAM) Workflow for Biosimilar mAb Drug Products Comparison on the Xevo™ G3 QTof Platform Kellen DeLaney, Samantha Ippoliti, Lisa Reid, Owen Cornwell, Ying Qing Yu, Emma Harry, Mark Towers Waters Corporation Abstract…
Key words
biosimilar, biosimilarmam, mamattribute, attributepeptide, peptidemapping, mappingapplying, applyingmab, mabdrug, drugworkflow, workflowmulti, multiproducts, productsmethod, methodattributes, attributesinnovator, innovatorthorough